Edition:
United States

HBM Healthcare Investments AG (HBMN.S)

HBMN.S on Swiss Exchange

170.00CHF
16 Oct 2018
Change (% chg)

CHF3.00 (+1.80%)
Prev Close
CHF167.00
Open
CHF167.80
Day's High
CHF170.00
Day's Low
CHF167.80
Volume
3,468
Avg. Vol
7,828
52-wk High
CHF184.80
52-wk Low
CHF120.10

Latest Key Developments (Source: Significant Developments)

HBM Healthcare Investments 9-Mth Profit At CHF 85.6 Mln
Thursday, 25 Jan 2018 12:45am EST 

Jan 25 (Reuters) - HBM HEALTHCARE INVESTMENTS AG ::PROFIT FOR THE FIRST NINE MONTHS OF THE 2017/2018 FINANCIAL YEAR AT A TOTAL OF CHF 85.6 MILLION.THE HBM HEALTHCARE INVESTMENTS PORTFOLIO REMAINS IN AN EXCELLENT POSITION IN CALENDAR 2018.  Full Article

HBM Healthcare Investments Expects Profit Of Over CHF 85 Million For First 9 Months Of 2017/2018‍​
Wednesday, 3 Jan 2018 11:51am EST 

Jan 3 (Reuters) - HBM HEALTHCARE INVESTMENTS ::FOR FIRST NINE MONTHS OF 2017/2018, EXPECTS A PROFIT OF OVER CHF 85 MILLION‍​.  Full Article

CSL And HBM Portfolio Company Vitaeris Announce Strategic Partnership
Tuesday, 5 Dec 2017 12:12pm EST 

Dec 5 (Reuters) - HBM HEALTHCARE INVESTMENTS ::CSL AND HBM PORTFOLIO COMPANY VITAERIS ANNOUNCE STRATEGIC PARTNERSHIP WITH OPTION TO ACQUIRE.  Full Article

BaseHealth raises $8.5 mln in Series C funding
Wednesday, 18 Oct 2017 07:00am EDT 

Oct 18 (Reuters) - BaseHealth:BaseHealth raises $8.5 million in Series C funding.BaseHealth - ‍overall investment of $8.5 million includes $2.5 million from lead investor HBM Healthcare Investments ​.  Full Article

HBM Healthcare Investments announces investment of $30 mln in Harmony Biosciences‍​
Friday, 6 Oct 2017 12:30am EDT 

Oct 6 (Reuters) - HBM HEALTHCARE INVESTMENTS AG ::ANNOUNCES INVESTMENT OF USD 30 MILLION IN HARMONY BIOSCIENCES‍​.  Full Article

HBM Healthcare Investments Q1 loss at CHF 72 million
Tuesday, 25 Jul 2017 12:32am EDT 

July 25 (Reuters) - HBM HEALTHCARE INVESTMENTS AG :Q1 LOSS 72 MILLION CHF.  Full Article

HBM Healthcare Investments FY net profit up at CHF 136.8 million
Tuesday, 16 May 2017 12:40am EDT 

May 16 (Reuters) - HBM HEALTHCARE INVESTMENTS AG ::PROPOSING AN INCREASE IN THE CASH DIVIDEND OF 30 CENTIMES, TO CHF 5.80 PER SHARE.EXPECTS THE LUTATHERA CANCER DRUG TO BE APPROVED TOWARDS THE END OF 2017.FY NET PROFIT OF CHF 136.8 MILLION VERSUS CHF 23.8 MILLION YEAR AGO.WILL CONTINUE TO MAKE SHAREHOLDER-FRIENDLY DISTRIBUTIONS AND SHARE BUY-BACKS.  Full Article

HBM Healthcare Investments commits EUR 20 mln in Amicus SA
Thursday, 27 Apr 2017 12:48am EDT 

April 27 (Reuters) - HBM Healthcare Investments AG ::Commits 20 million euros ($21.81 million) in growth capital to Switzerland based Amicus SA.Announced closing of a new equity investment of 20 million euros in two tranches into privately held and Switzerland based Amicus SA.Financing will allow Amicus to accelerate growth of its pharmaceutical business in Central and Eastern Europe (CEE).  Full Article

HBM Healthcare Investments FY net profit of around CHF 136 million
Tuesday, 4 Apr 2017 02:09am EDT 

HBM Healthcare Investments AG :Said on Monday expects to report a net profit of around 136 million Swiss francs ($135.76 million)for the financial year 2016/2017.  Full Article

BRIEF-HBM Healthcare Investments: Successful IPO Of Y-Mabs Therapeutics

* SUCCESSFUL IPO OF Y-MABS THERAPEUTICS INCREASES NET ASSET VALUE PER HBM-SHARE BY CHF 4.82 (+2.7%) Source text for Eikon: Further company coverage: (Gdynia Newsroom)